Variant report
Variant | nsv979395 |
---|---|
Chromosome Location | chr2:209899871-209910176 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:1)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
(count:1 , 50 per page) page:
1
No. | lncRNA name | Chromosome Location | lncRNA alias |
---|---|---|---|
1 | lnc-IDH1-4 | chr2:209907730-209907770 | NONHSAT076653 |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs561448597 | chr2:209901201-209901202 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs565468054 | chr2:209901202-209901203 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs147288009 | chr2:209901214-209901215 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs544381926 | chr2:209901268-209901269 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs561389906 | chr2:209901280-209901281 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs186275526 | chr2:209901293-209901294 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs34920888 | chr2:209901358-209901359 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs369331543 | chr2:209901377-209901378 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs372069695 | chr2:209901407-209901408 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs113050997 | chr2:209901420-209901421 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs559259406 | chr2:209901455-209901456 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs528363119 | chr2:209901487-209901488 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs551211356 | chr2:209901523-209901524 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs571358256 | chr2:209901544-209901545 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs547895423 | chr2:209901545-209901546 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs141024222 | chr2:209901547-209901548 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs548779171 | chr2:209901588-209901589 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs566924085 | chr2:209901590-209901591 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs144898104 | chr2:209901599-209901600 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs567327763 | chr2:209901620-209901621 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs191612316 | chr2:209901664-209901665 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs552989096 | chr2:209901702-209901703 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs144450212 | chr2:209901712-209901713 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs35538078 | chr2:209901737-209901738 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs148398723 | chr2:209901749-209901750 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs142578499 | chr2:209901778-209901779 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs115674527 | chr2:209901789-209901790 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs1522180 | chr2:209901853-209901854 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
29 | rs113070497 | chr2:209901879-209901880 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs369646345 | chr2:209901880-209901881 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs574862870 | chr2:209901881-209901882 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs540274059 | chr2:209901883-209901884 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs570899863 | chr2:209901937-209901938 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs560113320 | chr2:209901972-209901973 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs201821021 | chr2:209902087-209902088 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs62940160 | chr2:209902088-209902089 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs71041336 | chr2:209902119-209902120 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs375644476 | chr2:209902120-209902121 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs75030304 | chr2:209902150-209902151 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs180808696 | chr2:209902157-209902158 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs565154076 | chr2:209902174-209902175 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs184922425 | chr2:209902240-209902241 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs189794172 | chr2:209902390-209902391 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs183112738 | chr2:209902428-209902429 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs370018996 | chr2:209902439-209902440 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs187612666 | chr2:209902477-209902478 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs567283251 | chr2:209902486-209902487 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs536343804 | chr2:209902507-209902508 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs191493419 | chr2:209902608-209902609 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs556552833 | chr2:209902674-209902675 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Ependymoma | 16718352 | CNVD |
Melanoma | 18172304 | CNVD |
Cancer | 16751803 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Acute lymphoblastic leukemia | 21980252 | CNVD |
Breast cancer | 17603634 | CNVD |
Testicular germ cell tumor | 18059402 | CNVD |
Breast cancer | 16272173 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Cancer | 21637783 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Liposarcoma | 21253554 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Embryonal rhabdomyosarcoma | 16790082 | CNVD |
Autism | 16446308 | CNVD |
Autism | 19401682 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Lung cancer | 18438408 | CNVD |
Prostate cancer | 18632612 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Biliary cancer | 20360734 | CNVD |
Breast cancer | 20360734 | CNVD |
Coronary artery disease | 20360734 | CNVD |
Crohn''s disease | 20360734 | CNVD |
Hypertension | 20360734 | CNVD |
Rheumatoid arthritis | 20360734 | CNVD |
Type 1 diabetes | 20360734 | CNVD |
Type 2 diabetes | 20360734 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Cervical cancer | 21062161 | CNVD |
Adenoid cystic carcinoma | 18698036 | CNVD |
Non-muscle invasive bladder neoplasm | 19445696 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
Autism | 20808228 | CNVD |
Renal cell carcinoma | 18765545 | CNVD |
Ovarian cancer | 19193619 | CNVD |
Non-small cell lung cancer | 18676828 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Myofibroblastic sarcoma | 19369631 | CNVD |
Chordoma | 18071362 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Schizophrenia | 18923514 | CNVD |
Schizophrenia | 22241247 | CNVD |
Non-syndromic sensorineural hearing loss | 15273396 | CNVD |
Urothelial cell carcinoma | 18451213 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Developmental delay | 21147756 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr2:209901200-209902000 | Enhancers | iPS-15b Cell Line | embryonic stem cell |
2 | chr2:209901400-209901800 | Enhancers | H1 Cell Line | embryonic stem cell |
3 | chr2:209901400-209901800 | Enhancers | H1 BMP4 Derived Mesendoderm Cultured Cells | ES cell derived |
4 | chr2:209901400-209901800 | Enhancers | HUES6 Cell Line | embryonic stem cell |
5 | chr2:209901400-209902000 | Enhancers | ES-I3 Cell Line | embryonic stem cell |
6 | chr2:209901400-209902000 | Enhancers | HUES48 Cell Line | embryonic stem cell |
7 | chr2:209902000-209904400 | Weak transcription | iPS-15b Cell Line | embryonic stem cell |
8 | chr2:209904400-209904600 | Enhancers | iPS-15b Cell Line | embryonic stem cell |
9 | chr2:209908800-209909200 | Enhancers | Pancreatic Islets | Pancreatic Islet |